Revised forecast
Fiscal year ending March 2027 · Full yearPrevious forecast published 12 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
In the Chemotronics business, a temporary increase in demand occurred in the first half due to customers’ procurement concerns related to the situation in the Middle East, while market conditions improved in the Electronics business, particularly for power supplies used in semiconductor manufacturing equipment. Fixed-cost absorption from higher sales and cost reductions also progressed.
| Item | Details |
|---|---|
| Net Sales | ¥28,000 million → ¥30,000 million（+7.1%） |
| Operating profit | ¥200 million → ¥1,000 million（+400.0%） |
| Ordinary income | ¥550 million → ¥1,400 million（+154.5%） |
| Profit attributable to owners of the parent | ¥100 million → ¥1,000 million（+900.0%） |
| Net income per share | 19.03 Yen / sen → 193.98 Yen / sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Publication date of previous forecast | 12 May 2026 |
| Previous-period results | Fiscal year ending March 2026: net sales of ¥26,877 million, operating loss of ¥943 million, ordinary loss of ¥384 million, net loss attributable to owners of the parent of ¥2,220 million, and loss per share of ¥422.34. |
| Reason for the revision | In the Chemotronics business, a temporary increase in demand occurred in the first half due to customers’ procurement concerns related to the situation in the Middle East, while market conditions improved in the Electronics business, particularly for power supplies used in semiconductor manufacturing equipment. Fixed-cost absorption from higher sales and cost reductions also progressed. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Chemotronics business, customers’ procurement concerns related to the situation in the Middle East led to a temporary increase in demand in the first half, while market conditions improved in the Electronics business, particularly for power supplies used in semiconductor manufacturing equipment. In addition, higher sales improved fixed-cost absorption and cost reductions progressed.